Lupin gets USFDA approval for Zileuton Extended-Release Tablets, 600 mg

Lupins Zileuton Extended-Release Tablets, 600 mg are indicated for prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.

from India Infoline News Service https://ift.tt/32rygZv